← Open Payments lookup

KATIA HALL: Open Payments

NPI 1366865842 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$29,517 in 159 payments from 24 companies in 2025. Trend: 2023 $10,453 · 2024 $40,003 · 2025 $29,517

Speaker / faculty: $13,840Consulting: $9,860Food & beverage: $4,564Travel & lodging: $1,181Education: $71
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc45$26,104
ABBVIE INC.18$482
Otsuka America Pharmaceutical, Inc.14$317
Teva Pharmaceuticals USA, Inc.11$299
Alkermes, Inc.14$293
Eisai Inc.2$245
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$244
Neurocrine BioSciences, Inc.10$207
Axsome Therapeutics, Inc.8$166
Averitas Pharma Inc.1$150

Products named: SPRAVATO, VRAYLAR, ARISTADA, REXULTI, Leqembi, CAPLYTA, INGREZZA, Auvelity.

Industry payments across VA — which companies pay providers there.